Copyright
©2014 Baishideng Publishing Group Inc.
World J Nephrol. Aug 6, 2014; 3(3): 50-63
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.50
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.50
Cohort | Number of patients | Country | Result | Ref. |
Dialysis patients | 1957 | Netherlands | Higher mortality with very high or low BMI (< 65 yr) | [157] |
Kidney transplant | 1810 | Netherlands | Higher mortality and kidney graft failure | [158] |
Native population | 1924 | Sweden | Higher Chronic Renal Failure | [13] |
National Health and Nutrition Examination Survey III | 5659 | United States | Higher microalbuminuria with metabolic syndrome | [159] |
Hipertension and obesity | 4585 | Spain | Higher risk of renal insufficiency | [160] |
Native population | 2585 | United States | Higher risk of kidney disease | [12] |
Native population | 5403 | Japan | Higher risk of proteinuria | [161] |
Kidney transplant | 51927 | United States | Lower patient and graft survival. Higher chronic graft failure and delayed graft function | [162] |
Stages | Features |
1 and 2 | Hyperfiltration and renal hypertrophy |
3 | Microalbuminuria and hypertension as clinical features. As histological features: arteriolar hyalinosis, glomerular basement membrane thickening and mesangial matrix expansion |
4 (Diabetic Ne phropathy) | Proteinuria, nephrotic syndrome and decreased GFR |
5 | End-stage renal disease |
- Citation: Felizardo RJF, Silva MBD, Aguiar CF, Câmara NOS. Obesity in kidney disease: A heavyweight opponent. World J Nephrol 2014; 3(3): 50-63
- URL: https://www.wjgnet.com/2220-6124/full/v3/i3/50.htm
- DOI: https://dx.doi.org/10.5527/wjn.v3.i3.50